Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director
CC transcript
Asset disposition
Director comp.

LEXICON PHARMACEUTICALS, INC. (LXRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/07/2023 4 McDermott Wendy (VP, Human Resources) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Bought 6,000 shares @ $1.84, valued at $11k
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2023 4 COATS LONNEL (CEO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Bought 10,000 shares @ $2.16, valued at $21.6k
06/05/2023 4 Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Bought 27,775,050 shares @ $2.6, valued at $72.2M
04/28/2023 4 Swain Judith L (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Granted 8,032 restricted stock units @ $0
Granted 12,658 options to buy @ $2.36, valued at $29.9k
04/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2023 4 NIES ALAN S (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Granted 8,032 restricted stock units @ $0
Granted 12,658 options to buy @ $2.36, valued at $29.9k
04/28/2023 4 LEFKOWITZ ROBERT J MD (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Granted 8,032 restricted stock units @ $0
Granted 12,658 options to buy @ $2.36, valued at $29.9k
04/28/2023 4 DEBBANE RAYMOND (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Granted 8,032 restricted stock units @ $0
Granted 12,658 options to buy @ $2.36, valued at $29.9k
04/28/2023 4 BARKER SAM L (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Granted 8,032 restricted stock units @ $0
Granted 12,658 options to buy @ $2.36, valued at $29.9k
04/28/2023 4 Amouyal Philippe (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Granted 8,032 restricted stock units @ $0
Granted 12,658 options to buy @ $2.36, valued at $29.9k
03/01/2023 4 Alexander Kristen (VP, Finance and Accounting) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 5,330 shares @ $2.17, valued at $11.6k
Exercised 5,400 restricted stock units @ $0
Exercised 2,700 restricted stock units @ $0
Exercised 10,617 restricted stock units @ $0
03/01/2023 4 Seth Kiernan (VP, Chief Commercial Officer) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 11,813 shares @ $2.17, valued at $25.6k
Exercised 14,833 restricted stock units @ $0
Exercised 5,286 restricted stock units @ $0
Exercised 22,963 restricted stock units @ $0
03/01/2023 4 McDermott Wendy (VP, Human Resources) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 6,465 shares @ $2.17, valued at $14k
Exercised 18,943 restricted stock units @ $0
03/01/2023 4 MAIN ALAN J (EVP, Innov & Chem Sciences) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 20,946 shares @ $2.17, valued at $45.5k
Exercised 23,300 restricted stock units @ $0
Exercised 8,976 restricted stock units @ $0
Exercised 25,667 restricted stock units @ $0
03/01/2023 4 Kassler-Taub Kenneth B. (SVP, Regulatory & QA) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 19,118 shares @ $2.17, valued at $41.5k
Exercised 18,243 restricted stock units @ $0
Exercised 7,086 restricted stock units @ $0
Exercised 27,557 restricted stock units @ $0
03/01/2023 4 Granowitz Craig B (SVP, Chief Medical Officer) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 12,732 shares @ $2.17, valued at $27.6k
Exercised 27,917 restricted stock units @ $0
03/01/2023 4 Crum Brian T (SVP, General Counsel & Secr.) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 20,537 shares @ $2.17, valued at $44.6k
Exercised 21,030 restricted stock units @ $0
Exercised 8,750 restricted stock units @ $0
Exercised 26,097 restricted stock units @ $0
03/01/2023 4 WADE JEFFREY L (President and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 30,255 shares @ $2.17, valued at $65.7k
Exercised 30,467 restricted stock units @ $0
Exercised 11,176 restricted stock units @ $0
Exercised 37,273 restricted stock units @ $0
03/01/2023 4 COATS LONNEL (CEO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 50,971 shares @ $2.17, valued at $110.6k
Exercised 84,630 restricted stock units @ $0
Exercised 33,334 restricted stock units @ $0
Exercised 91,363 restricted stock units @ $0
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2022 4 Invus US Partners LLC (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Bought 147,390 shares @ $2.5, valued at $368.5k
08/09/2022 4 Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.
Txns: Bought 2,426,070 shares @ $2.5, valued at $6.1M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy